Behçet's disease other diagnostic studies

Jump to navigation Jump to search

Behçet's disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Behçet's disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Behçet's disease other diagnostic studies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Behçet's disease other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Behçet's disease other diagnostic studies

CDC on Behçet's disease other diagnostic studies

Behçet's disease other diagnostic studies in the news

Blogs on Behçet's disease other diagnostic studies</smal

Directions to Hospitals Treating Behçet's disease

Risk calculators and risk factors for Behçet's disease other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hamid Qazi, MD, BSc [2] Dheeraj Makkar, M.D.[3]

Overview

There are no other diagnostic studies associated with Behçet disease. Laboratory findings in Behçet’s are nonspecific. The key points are:

No definitive diagnostic biomarker exists.

HLA-B*51 is strongly associated but not diagnostic.

Inflammatory markers and immune dysregulation (Th1/Th17 skew, neutrophil activation, NF-κB signaling) are characteristic but not used in routine clinical practice.

Labs are primarily used to support diagnosis, assess inflammation, and exclude mimicking conditions .


Other diagnostic studies

Laboratory Findings in Behçet’s Syndrome

  • Lack of Specific Biomarkers

Behçet’s has no pathognomonic laboratory or histologic diagnostic test.

Laboratory tests are mainly used to exclude other differential diagnoses.

  • Genetic Associations

HLA-B*51: strongest genetic risk factor, but its high prevalence in the general population limits diagnostic utility.

Other genes (ERAP1, IL23R–IL12RB2, STAT4, IL10, TNFAIP3, MEFV, TLR4, NOD2, FUT2) linked through GWAS, but not used as routine clinical tests.

  • Inflammatory and Immunologic Findings

Innate and adaptive immune abnormalities noted:

↑ Th1 cytokines (TNF-α, IFN-γ).

↑ Th17 cytokines (IL-17, IL-23).

↓ Regulatory T-cell activity.

Neutrophils: hyperactive, producing excess reactive oxygen species (ROS) and releasing neutrophil extracellular traps (NETs).

NF-κB pathway: heightened activity in antigen-presenting cells, neutrophils, and T-helper cells.

  • Histopathology

Biopsy specimens (e.g., skin):

Leukocytoclastic vasculitis.

Neutrophilic or lymphocytic perivascular infiltrates.

Microvascular thrombi.

Neutrophilic dermal infiltrates.

  • Laboratory Workup in Differential Diagnosis

When evaluating mucocutaneous and systemic manifestations, suggested labs include:

Blood tests: CBC, CRP, iron, zinc, folate, vitamins B1, B6, B12.

Immunologic tests: ANA, anti-desmoglein antibodies, anti-transglutaminase antibodies, HLA-B27, ACE levels.

Infectious serologies: HIV, herpes, syphilis, CMV, tuberculosis testing as indicated.

Coagulation/thrombophilia screening for vascular events (e.g., antiphospholipid antibodies, myeloproliferative syndromes).

Other Diagnostic Studies

There are no other diagnostic studies associated with Behçet disease.

References

Template:WH Template:WS